ZOFRAN ODT orally disintegrating tablets are white, round, and plano-convex tablets available in the following strengths: • 4 mg – debossed with “Z4” on one side. • 8 mg – debossed with “Z8” …

The active ingredient in ZOFRAN Injection is ondansetron hydrochloride (HCl), the racemic form of ondansetron and a selective blocking agent of the serotonin 5-HT 3

Sep 16, 2024 · See full prescribing information for ZOFRAN TABLETS, ZOFRAN ODT, and ZOFRAN ORAL SOLUTION. ZOFRAN is a 5-HT 3 receptor antagonist indicated for the …

Feb 18, 2025 · Ondansetron package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.

Ondansetron oral solution is indicated for the prevention of nausea and vomiting associated with: highly emetogenic cancer chemotherapy, including cisplatin greater than or equal to 50 mg/m …

ZOFRAN® Injection is indicated for the prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including high-dose cisplatin. …

ZOFRAN ODT Tablets are a freeze-dried, orally administered formulation of ondansetron which rapidly disintegrates on the tongue and does not require water to aid dissolution or swallowing. …

ZOFRAN (ondansetron hydrochloride; and ondansetron) is indicated for: the prevention of nausea and vomiting associated with emetogenic chemotherapy, including high dose cisplatin, and …

ZOFRAN ODT orally disintegrating tablets are white, round, and plano-convex tablets available in the following strengths: 4 mg – debossed with “Z4” on one side.

Ondansetron orally disintegrating tablets, USP are orally administered formulation of ondansetron which rapidly disintegrates on the tongue and does not require water to aid dissolution or …